Goujard C - Search Results

1

Evidence for a continuous drift of the HIV-1 species towards higher resistance to neutralizing antibodies over the course of the epidemic.

Bouvin-Pley M, Morgand M, Moreau A, Jestin P, Simonnet C, Tran L, Goujard C, Meyer L, Barin F, Braibant M. Bouvin-Pley M, et al. Among authors: goujard c. PLoS Pathog. 2013;9(7):e1003477. doi: 10.1371/journal.ppat.1003477. Epub 2013 Jul 4. PLoS Pathog. 2013. PMID: 23853594 Free PMC article.

2

Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection.

Dalod M, Dupuis M, Deschemin JC, Goujard C, Deveau C, Meyer L, Ngo N, Rouzioux C, Guillet JG, Delfraissy JF, Sinet M, Venet A. Dalod M, et al. Among authors: goujard c. J Clin Invest. 1999 Nov;104(10):1431-9. doi: 10.1172/JCI7162. J Clin Invest. 1999. PMID: 10562305 Free PMC article.

3

[Primary HIV-1 infection].

Meyer L, Goujard C. Meyer L, et al. Among authors: goujard c. Rev Prat. 1999 Oct 15;49(16):1750-5. Rev Prat. 1999. PMID: 10578605 French.

4

Incidence of clinical lipodystrophy in HIV-infected patients treated during primary infection.

Goujard C, Boufassa F, Deveau C, Laskri D, Meyer L; PRIMO group. Goujard C, et al. AIDS. 2001 Jan 26;15(2):282-4. doi: 10.1097/00002030-200101260-00024. AIDS. 2001. PMID: 11216943 No abstract available.

5

Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological response.

Boufassa F, Dulioust A, Lascaux AS, Meyer L, Boué F, Delfraissy JF, Sobel A, Goujard C. Boufassa F, et al. Among authors: goujard c. HIV Clin Trials. 2001 Jul-Aug;2(4):339-45. doi: 10.1310/BRE5-448N-WUPU-JWVL. HIV Clin Trials. 2001. PMID: 11590538 Clinical Trial.

6

Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment.

Harzic M, Pellegrin I, Deveau C, Chaix ML, Dubeaux B, Garrigue I, Ngo N, Rouzioux C, Goujard C, Hoen B, Sereni D, Delfraissy JF, Meyer L; PRIMO Study Group. Harzic M, et al. Among authors: goujard c. AIDS. 2002 Mar 29;16(5):793-6. doi: 10.1097/00002030-200203290-00017. AIDS. 2002. PMID: 11964538 No abstract available.

7

Increase in at-risk sexual behaviour among HIV-1-infected patients followed in the French PRIMO cohort.

Desquilbet L, Deveau C, Goujard C, Hubert JB, Derouineau J, Meyer L; PRIMO Cohort Study Group. Desquilbet L, et al. Among authors: goujard c. AIDS. 2002 Nov 22;16(17):2329-33. doi: 10.1097/00002030-200211220-00014. AIDS. 2002. PMID: 12441806

8

Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.

Lacabaratz-Porret C, Urrutia A, Doisne JM, Goujard C, Deveau C, Dalod M, Meyer L, Rouzioux C, Delfraissy JF, Venet A, Sinet M. Lacabaratz-Porret C, et al. Among authors: goujard c. J Infect Dis. 2003 Mar 1;187(5):748-57. doi: 10.1086/368333. Epub 2003 Feb 18. J Infect Dis. 2003. PMID: 12599048 Clinical Trial.

9

CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection.

Doisne JM, Urrutia A, Lacabaratz-Porret C, Goujard C, Meyer L, Chaix ML, Sinet M, Venet A. Doisne JM, et al. Among authors: goujard c. J Immunol. 2004 Aug 15;173(4):2410-8. doi: 10.4049/jimmunol.173.4.2410. J Immunol. 2004. PMID: 15294954

10

Does transient HAART during primary HIV-1 infection lower the virological set-point?

Desquilbet L, Goujard C, Rouzioux C, Sinet M, Deveau C, Chaix ML, Séréni D, Boufassa F, Delfraissy JF, Meyer L; PRIMO and SEROCO Study Groups. Desquilbet L, et al. Among authors: goujard c. AIDS. 2004 Dec 3;18(18):2361-9. AIDS. 2004. PMID: 15622312

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

470 results

Search Page

Filters